Exercise and quality of life in early breast cancer on hormone therapy
Part of Cancer, Skin clinical trials.
This trial tests if a supervised exercise program can improve quality of life for people with early-stage breast cancer who are currently taking hormone therapy (aromatase inhibitors with or without CDK4/6 inhibitors). It aims to see if exercise helps reduce side effects like fatigue and pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have early-stage breast cancer that is hormone receptor-positive and HER2-negative.
- You have been taking an aromatase inhibitor (a type of hormone therapy) for at least 10 weeks but no more than 18 weeks.
- If you are also taking a CDK4/6 inhibitor, you must have started it at least 6 weeks ago.
- You are able and willing to do a supervised exercise program, including using a website or app for training sessions.
- You speak and understand Spanish fluently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a structured exercise program can improve cardiovascular (heart and blood vessel) health in post-menopausal women after early-stage breast cancer treatment. It specifically targets women who have trouble with exercise and have completed cancer treatment within the last 1 to 5 years.
This study tests an exercise intervention for people with early-to-mid stage breast cancer soon after curative breast surgery (and after chemo and/or radiation if you had it). It may help improve recovery, physical strength, and overall wellbeing by making exercise safer and more structured during this period.
This study tests whether a structured exercise program helps women with early-stage hormone-positive breast cancer who are taking endocrine therapy (hormone-blocking medications). The goal is to see if physical activity improves outcomes and quality of life during treatment.
This study tests whether a personalized 14-week exercise program, guided by a physiotherapist, can help people with breast cancer during their chemotherapy or hormone therapy before surgery. It also looks at certain biological markers in blood or tissue samples to learn more about how the body responds to treatment and exercise.
This study tests whether supervised exercise during chemotherapy is safe and helpful for people with early-stage breast cancer. It may support physical function and well-being while you are receiving cancer treatment.
This study tests whether a supervised exercise program during chemotherapy helps women with breast cancer keep their muscle strength and fitness. You would receive your usual chemotherapy while also participating in guided exercise sessions.
Hear when a new Early-stage Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.